High expression of phosphorylated ACK1 correlates with disease progression in breast, prostate and pancreatic cancers [12-14], with specific interactions between the ACK1 kinase and key signaling nodes e.g. androgen receptors in prostate cancer. This evidence concerns the gene TNK2 and pancreatic neoplasm.